Apontis Pharma AG

As of June 30, 2025, Apontis Pharma AG has 8.33M shares outstanding.

As of June 30, 2025, Apontis Pharma AG maintains a current ratio of 7.78, meaning it holds 7.8x the short-term assets needed to cover near-term liabilities.

As of the close on November 17, 2025, Apontis Pharma AG's stock has gained approximately 12.70% over the past 52 weeks. The 50-day moving average sits at 10.87, while the 200-day moving average is 11.07.

As of June 30, 2025, Apontis Pharma AG has an Altman Z-Score of 0.28, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.